These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29399201)

  • 1. Role of prolactin/adenoma maximum diameter and prolactin/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas.
    Huang Y; Ding C; Zhang F; Xiao D; Zhao L; Wang S
    Oncol Lett; 2018 Feb; 15(2):2010-2016. PubMed ID: 29399201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
    Kim JH; Hur KY; Hong SD; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
    World Neurosurg; 2022 Mar; 159():e488-e496. PubMed ID: 34958988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas.
    Wright K; Lee M; Escobar N; Pacione D; Young M; Fatterpekar G; Agrawal N
    Endocrine; 2021 Oct; 74(1):138-145. PubMed ID: 33966173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
    Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
    Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin receptors in human pituitary adenomas.
    Ciccarelli E; Faccani G; Longo A; Dalle Ore G; Papotti M; Grottoli S; Razzore P; Ghè C; Muccioli G
    Clin Endocrinol (Oxf); 1995 May; 42(5):487-91. PubMed ID: 7621567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size.
    Burke WT; Penn DL; Castlen JP; Donoho DA; Repetti CS; Iuliano S; Barkhoudarian G; Laws ER
    J Neurosurg; 2019 Jun; 133(2):321-328. PubMed ID: 31200381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of calcium channel antagonist (nicardipine) on growth hormone and prolactin secretion in pituitary adenomas].
    Kabuto M; Hayashi M; Kubota T; Kobayashi H; Nakagawa T; Katsumura H; Hosotani K
    No To Shinkei; 1991 Jul; 43(7):637-43. PubMed ID: 1910948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of acromegaly in patients with prolactinomas.
    Andersen M; Hagen C; Frystyk J; Schroeder HD; Hagen C
    Eur J Endocrinol; 2003 Jul; 149(1):17-22. PubMed ID: 12824861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W; Ikeda H; Yoshimoto T
    Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolactin producing adenoma].
    Tamaki N; Yonezawa K
    Nihon Rinsho; 1993 Oct; 51(10):2685-90. PubMed ID: 8254940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
    Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
    Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis.
    Leca BM; Mytilinaiou M; Tsoli M; Epure A; Aylwin SJB; Kaltsas G; Randeva HS; Dimitriadis GK
    Sci Rep; 2021 May; 11(1):9801. PubMed ID: 33963239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia and associated pituitary prolactinomas.
    Brenner SH; Lessing JB; Quagliarello J; Weiss G
    Obstet Gynecol; 1985 May; 65(5):661-4. PubMed ID: 4039046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falsely low serum prolactin in two cases of invasive macroprolactinoma.
    Schöfl C; Schöfl-Siegert B; Karstens JH; Bremer M; Lenarz T; Cuarezma JS; Samii M; von zur Mühlen A; Brabant G
    Pituitary; 2002; 5(4):261-5. PubMed ID: 14558675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of dopaminergic regulation of prolactin in patients with functioning and nonfunctioning pituitary adenomas and craniopharyngiomas.
    Martinez-Campos A; Cornejo J; Garza-Flores J; Velasco F
    Fertil Steril; 1985 Oct; 44(4):471-7. PubMed ID: 4054318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.